-+ 0.00%
-+ 0.00%
-+ 0.00%

JADE BIOSCIENCES INC: EXPECTS TO INITIATE A PHASE 2 CLINICAL TRIAL IN PATIENTS WITH IGAN MID-2026, WITH PRELIMINARY DATA ANTICIPATED IN 2027

Reuters·03/06/2026 12:00:01

Please log in to view news